Direct Meds GLP-1 vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Direct Meds GLP-1 beats Gala overall, scoring 7.9/10 vs 7.2/10. Gala is more affordable at $149/mo vs $297/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa.
A side-by-side look at Direct Meds GLP-1 and Gala to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Direct Meds GLP-1
#10 of 53Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.
Visit Direct Meds GLP-1Gala
#39 of 53Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit Gala| Feature | Direct Meds GLP-1 | Gala |
|---|---|---|
| Our Score | 7.9/10 | 7.2/10 |
| Starting Price | $297/mo | $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users wanting simple, all-inclusive pricing without insurance | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging |
| Watch out for | Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu | Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide. |
| Ranking | #10 | #39 |
| Get started | Visit Direct Meds GLP-1 | Visit Gala |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +True all-inclusive pricing, $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
- +Clear dose-based pricing published on their site, no surprise cost increases when titrating up
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
- −The $280/mo flat rate sits above Henry Meds ($199) and TrimRx ($149); Direct Meds' own sublingual drops at $179 are the budget path if the premium stings
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
- −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Our Verdict
Direct Meds GLP-1 edges out Gala with a score of 7.9/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to Direct Meds GLP-1's $297/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Direct Meds GLP-1 nor Gala feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Direct Meds GLP-1 or Gala tend to look at next.
- Direct Meds GLP-1 vs MyStart Health$299/mo
- Direct Meds GLP-1 vs Telos RX$249/mo
- Direct Meds GLP-1 vs Willow$299/mo
- Gala vs MEDVi$179/mo
- Gala vs bmiMD$119/mo
- Gala vs Found$129/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.